Abbreviations and Acronyms
The acronyms on this page are commonly used across research, especially human subject research. Asterisks (*) indicate that the acronym is specific to the University of Rochester.
You can also download a printable version of this guide for your records.
A
- AAHRPP: Association for the Accreditation of Human ÌÇÐÄlogo Protection ProgramsÌý
- AARC*: Administrative ÌÇÐÄlogo Review Committee (Highland Hospital)Ìý
- ACRP: Association of Clinical ÌÇÐÄlogo ProfessionalsÌý
- ADE:
- Adverse Drug Event
- Adverse Drug ExperienceÌý
- ADME: Absorption, Distribution, Metabolism, and Elimination
- ADR: Adverse Drug ReactionÌý
- AE: Adverse EventÌý
- ALCOAC: Accurate, Legible, Contemporaneous, Original, Attributable, and CompleteÌý
- ARO: Academic ÌÇÐÄlogo Organization
B
- BAA: Business Associates AgreementÌý
- BA/BE: Bioavailability/Bioequivalence
- BIMO: Bioresearch Monitoring Program (FDA)Ìý
C
- CABIN*: Center for Advanced Brain Imaging & Neurophysiology (formerly Rochester Center for Brain Imaging)Ìý
- CAPA: Corrective and Preventative ActionÌý
- CART*: Center for Advanced ÌÇÐÄlogo Technologies
- CBER: Center for Biologics Evaluation and ÌÇÐÄlogo (FDA)Ìý
- CC: Coordinating Center
- CCC: Clinical Coordinating Center
- CCEA: Complete, Consistent, Enduring, Available
- CCRA: Certified Clinical ÌÇÐÄlogo AssociateÌý
- CCRC: Certified Clinical ÌÇÐÄlogo CoordinatorÌý
- CCRP: Certified Clinical ÌÇÐÄlogo ProfessionalÌý
- CDA: Confidential Disclosure Agreement
- CDER: Center for Drug Evaluation and ÌÇÐÄlogo (FDA)Ìý
- CDP: Clinical Development Plan
- CDS: Clinical Data System
- CEL*: Center for Experiential LearningÌý
- CFR: Code of Federal RegulationsÌý
- CHeT*: Center for Health and TechnologyÌý
- CIDUR*: Clinical Imaging Data for UR ÌÇÐÄlogoers
- CISCRP: Center for Information and Study on Clinical ÌÇÐÄlogo ParticipationÌý
- CIOMS: Council for International Organizations of Medical SciencesÌý
- cIRB: Central Institutional Review BoardÌý
- CITI: Collaborative Institutional Training InitiativeÌý
- CLIA: Clinical Laboratory Improvement AmendmentsÌý
- CME: Continuing Medical Education
- CMSU*: Clinical Materials Service UnitÌý
- CoC: Certificate of Confidentiality
- COI: Conflict of InterestÌý
- CPI: Certified Principal InvestigatorÌý
- CR*: Continuing Review (Click IRB)Ìý
- CRA: Clinical ÌÇÐÄlogo AssociateÌý
- CRC:ÌýÌý
-
- Clinical ÌÇÐÄlogo Center* (CTSI)
- Clinical ÌÇÐÄlogo CoordinatorÌý
- CRF: Case Report FormÌý
- CRO: Clinical ÌÇÐÄlogo OrganizationÌý
- CSR: Clinical Study ReportÌý
- CT: Clinical TrialÌý
- CTA: Clinical Trial AgreementÌý
- CTCC*: Clinical Trials Coordination CenterÌý
- CTM: Clinical Trial MaterialÌý
- CTMS: Clinical Trial Management SystemÌý
- CTO*: Clinical Trial Office (Cancer Center)Ìý
- CTPL: Clinical Trials Processing Laboratory
- CTSA: Clinical & Translational Science Award
- CTSI*: Clinical & Translational Science InstituteÌý
- CTTI: Clinical Trials Transformation InitiativeÌý
- CV: Curriculum VitaeÌý
D
- DB: Double BlindÌý
- DCC: Data Coordinating Center
- DCF:ÌýÌý
-
- Data Correction FormÌý
- Data Clarification FormÌý
- DHHS (HHS): Department of Health & Human ServicesÌý
- DM: Data Manager
- DMC: Data Monitoring CommitteeÌý
- DMP: Data Management PlanÌý
- DROIPR*: Department of Radiation Oncology Protocol Review CommitteeÌý
- DSMB: Data and Safety Monitoring BoardÌý
- DSME: Data and Safety Monitoring Entity
- DSMP: Data and Safety Monitoring PlanÌý
- DUA: Data Use AgreementÌý
E
- EAC: Endpoint Adjudication Committee
- EC:ÌýÌý
-
- Ethics CommitteeÌý
- European CommissionÌý
- ECI: Event of Clinical InterestÌý
- eCRF: Electronic Case Report FormÌý
- EDC: Electronic Data CaptureÌý
- EDRA*: Emergency Department ÌÇÐÄlogo AssociateÌý
- EHR: Electronic Health RecordÌý
- EIR: Establishment Inspection ReportÌý
- EMR: Electronic Medical RecordÌý
- EMRC*: Emergency Medicine ÌÇÐÄlogo CommitteeÌý
- ePRO: Electronic Patient Reported OutcomesÌý
- eTMF: Electronic Trial Master FileÌý
F
- fCOI: Financial Conflict of Interest
- FDA: Food and Drug AdministrationÌý
- FERPA: Family Educational Rights and Privacy Act
- FWA: Federalwide AssuranceÌý
GÌý
- GCP: Good Clinical PracticeÌý
- GDP: Good Documentation Practice
- GDPR: General Data Protection Regulations (European Union)
- GLP: Good Laboratory PracticeÌý
- GMP: Good Manufacturing PracticeÌý
H
- HIPAA: Health Insurance Portability & Accountability ActÌý
- HRPP: Human ÌÇÐÄlogo Protection ProgramÌý
- HSP: Human Subject Protection
- HUD: Humanitarian Use DeviceÌý
- HURC*: Human Use of Radiation CommitteeÌý
I
- IB: Investigator’s BrochureÌý
- IBC: Institutional Biosafety CommitteeÌý
- ICF: Informed Consent FormÌý
- ICH: International Conference on HarmonisationÌý
- IDE: Investigational Device ExemptionÌý
- IDMC: Independent Data Monitoring CommitteeÌý
- IDS*: Investigational Drug ServiceÌý
- IEC: Independent Ethics CommitteeÌý
- IIT: Investigator-Initiated Trial
- IND: Investigational New DrugÌý
- INDSR: Investigational New Drug Safety ReportÌý
- IO: Institutional OfficialÌý
- IORA*: Integrated Online ÌÇÐÄlogo AdministrationÌý
- IP: Investigational ProductÌý
- IRB: Institutional Review BoardÌý
- IRBC*: Institutional Review Board CoordinatorÌý
- IRBD*: Institutional Review Board DirectorÌý
- ISO: International Standards Organization
- ITT: Intent to Treat
- IVRS: Interactive Voice Response SystemÌý
- IWRS: Interactive Web Response SystemÌý
J
- JIT: Just-in-TimeÌý
L
- LAR: Legally Authorized RepresentativeÌý
- LDS: Limited Data SetÌý
- LOI: Letter of Intent
- LTFU: Long Term Follow Up
M
- MAC: Medicare Administration Contractor
- MCA: Medicare Coverage Analysis
- MOD*: Modification (Click IRB)Ìý
- MOD/CR*: Modification & Continuing Review (Click IRB)Ìý
- MOO: Manual of OperationsÌý
- MOP: Manual of ProceduresÌý
- MRCT: Multi-Regional Clinical Trials CenterÌý
- MSS: Multi-Site StudyÌý
- MTA: Material Transfer AgreementÌý
N
- NAF: Notice of Adverse FindingsÌý
- NAI: No Action IndicatedÌý
- NCD: National Coverage Determination
- NCTG*: Neonatal Clinical Trials GroupÌý
- NDA: New Drug ApplicationÌý
- NIH: National Institutes of Health
- NOA: Notice of Award
- NOFO: Notice of Funding Opportunity
- NTF: Note to FileÌý
O
- OAI: Official Action IndicatedÌý
- OCR:ÌýÌý
-
- Office of Civil RightsÌý
- Office of Clinical ÌÇÐÄlogo* (CTSI)
- OHRP: Office for Human ÌÇÐÄlogo ProtectionsÌý
- OHSP*: Office for Human Subject ProtectionÌý
- OIG: Office of the Inspector General
- ORACS*: Office of ÌÇÐÄlogo Accounting and Costing StandardsÌý
- ORC*: Obstetrical ÌÇÐÄlogo CommitteeÌý
- ORPA*: Office of ÌÇÐÄlogo & Project AdministrationÌý
- ORS*: Office of Regulatory Support (CTSI)
- OSMB: Observational Study Monitoring BoardÌý
- OVPR*: Office of the Vice President for ÌÇÐÄlogoÌý
P
- PAC: Post-Approval Consultation
- PD: PharmacodynamicÌý
- PHI: Protected Health InformationÌý
- PHS: Public Health ServiceÌý
- PI: Principal InvestigatorÌý
- PIPL: Personal Information Protection Law (China)
- PK/PD: Pharmacokinetic/Pharmacodynamic
- PM: Project ManagerÌý
- PMA: Premarket ApprovalÌý
- PRIM&R: Public Responsibility in Medicine and ÌÇÐÄlogoÌý
- PRO: Patient Reported OutcomesÌý
- PROMIS: Patient Reported Outcomes Measurement Information SystemÌý
- pSite: Participating Site
Q
- QA: Quality AssuranceÌý
- QC: Quality ControlÌý
- QCT: Qualifying Clinical Trial
- QI: Quality ImprovementÌý
- QMP: Quality Management Plan
R
- RBM: Risk Based MonitoringÌý
- RCT: Randomized Controlled TrialÌý
- RCR: Responsible Conduct of ÌÇÐÄlogo
- RDE: Remote Data EntryÌý
- REB: ÌÇÐÄlogo Ethics BoardÌý
- RESIN: Rochester Early-Stage Investigator Network
- RHIO: Rochester Regional Health Information Organization
- RMF: ÌÇÐÄlogo Methods Forum
- RNI*: Reportable New Information (Click IRB)Ìý
- ROPI: Report of Prior InvestigationsÌý
- RSA: ÌÇÐÄlogo Subject AdvocateÌý
- RSRB*: ÌÇÐÄlogo Subjects Review BoardÌý
S
- SADE: Serious Adverse Drug ExperienceÌý
- SAE: Serious Adverse EventÌý
- SC:ÌýÌý
-
- Safety CohortÌý
- Study CoordinatorÌý
- SubcutaneousÌý
- SCORE*: Study Coordinators Organization for ÌÇÐÄlogo & EducationÌý
- SCRS: Society for Clinical ÌÇÐÄlogo SitesÌý
- SDV: Source Document VerificationÌý
- SI: Sponsor-Investigator
- sIRB: Single Institutional Review BoardÌý
- SIV: Site Initiation Visit
- SMO: Site Management OrganizationÌý
- SO: Safety OfficerÌý
- SOC: Standard of Care
- SOCRA: Society of Clinical ÌÇÐÄlogo AssociatesÌý
- SOE: Schedule of Events
- SOP: Standard Operating ProcedureÌý
- SRO: Scientific Review Officer
- SUSAR: Suspected Unexpected Serious Adverse ReactionÌý
T
- TIN: Trial Innovation Network
- TMF: Trial Master FileÌý
- TMO: Trial Management Organization
U
- UADE: Unanticipated Adverse Device EffectÌý
- UADR: Unanticipated Adverse Drug Reaction
- UAP: Unanticipated ProblemÌý
- UPIRTSO: Unanticipated Problem Involving Risk to Subjects or OthersÌý
V
- VAI: Voluntary Action IndicatedÌý
W
- WCG: WIRB Copernicus Group
- WCI PRMC*: Wilmot Cancer Institute Protocol Review and Monitoring Committee
- WIRB: Western Institutional Review Board
*Specific to the University of Rochester